Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Kiniksa Pharmaceuticals International, plc | 82,000 | reported | 17 Sept 2019 | tx 8+334,834−113,442 |
| Viridian Therapeutics, Inc.\DE | 33,349 | reported | 03 Mar 2026 | tx 10+2,484,650−33,392 |
| Dianthus Therapeutics, Inc. /DE/ | 17,264 | reported | 30 Nov 2022 | tx 7+780,500−5,736 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 03 Mar 2026 | TAX_WITHHOLDING | Viridian Therapeutics, Inc.\DE | 7,627 | 29.32 USD | |
| 03 Mar 2026 | EXERCISE | Viridian Therapeutics, Inc.\DE | 18,357 | — | |
| 02 Mar 2026 | GRANT_AWARD | Viridian Therapeutics, Inc.\DE | 111,900 | 0.00 USD | deriv |
| 02 Mar 2026 | GRANT_AWARD | Viridian Therapeutics, Inc.\DE | 559,600 | 0.00 USD | deriv |
| 03 Mar 2026 | EXERCISE | Viridian Therapeutics, Inc.\DE | 18,357 | 0.00 USD | deriv |
| 03 Mar 2025 | GRANT_AWARD | Viridian Therapeutics, Inc.\DE | 73,428 | 0.00 USD | deriv |
| 03 Mar 2025 | GRANT_AWARD | Viridian Therapeutics, Inc.\DE | 440,565 | 0.00 USD | deriv |
| 27 Sept 2024 | PURCHASE | Viridian Therapeutics, Inc.\DE | 21,400 | 23.33 USD | first after silence |
| 30 Oct 2023 | GRANT_AWARD | Viridian Therapeutics, Inc.\DE | 1,259,400 | 0.00 USD | deriv |
| 30 Nov 2022 | GRANT_AWARD | Dianthus Therapeutics, Inc. /DE/ | 3,000 | 0.94 USD | |
| 01 Aug 2022 | GRANT_AWARD | Dianthus Therapeutics, Inc. /DE/ | 130,000 | 0.00 USD | deriv |
| 17 May 2022 | GRANT_AWARD | Dianthus Therapeutics, Inc. /DE/ | 62,500 | 0.00 USD | deriv |
| 15 Feb 2022 | GRANT_AWARD | Dianthus Therapeutics, Inc. /DE/ | 130,000 | 0.00 USD | deriv |
| 16 Sept 2021 | SALE | Dianthus Therapeutics, Inc. /DE/ | 5,736 | 6.73 USD | |
| 14 Sept 2021 | GRANT_AWARD | Dianthus Therapeutics, Inc. /DE/ | 20,000 | 0.00 USD | |
| 02 Nov 2020 | GRANT_AWARD | Dianthus Therapeutics, Inc. /DE/ | 435,000 | 0.00 USD | deriv |
| 17 Sept 2019 | GRANT_AWARD | Kiniksa Pharmaceuticals International, plc | 82,000 | 0.00 USD | deriv |
| 04 Mar 2019 | GRANT_AWARD | Kiniksa Pharmaceuticals International, plc | 83,000 | 0.00 USD | deriv |
| 20 Sept 2018 | GRANT_AWARD | Kiniksa Pharmaceuticals International, plc | 50,000 | 0.00 USD | deriv |
| 29 May 2018 | CONVERSION | Kiniksa Pharmaceuticals International, plc | 6,392 | 0.00 USD | |
| 29 May 2018 | CONVERSION | Kiniksa Pharmaceuticals International, plc | 107,050 | 0.00 USD | deriv |
| 29 May 2018 | CONVERSION | Kiniksa Pharmaceuticals International, plc | 6,392 | 0.00 USD | deriv |
| 29 May 2018 | CONVERSION | Kiniksa Pharmaceuticals International, plc | 107,050 | 0.00 USD | deriv |
| 09 Feb 2018 | PURCHASE | Kiniksa Pharmaceuticals International, plc | 6,392 | 15.64 USD | deriv |
1 purchase reported after at least 12 months of silence — most recent on 27 Sept 2024.